Vol. 7, Issue 2, Part C (2025)
| S. No. | Title and Authors Name |
|---|---|
| 1 |
Evaluation of antibacterial activity of Coleus aromaticus stem extract in ointment formulations
Ramdas Bhat, Bhavyashree K, Charan DS, Deeksha, Deepa K and Deepak
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 177-181
|
| 2 |
Irritant contact dermatitis after topical application of an unverified ayurvedic oil: A case report
Rachana MS, Manasa R, Rashmitha R and Janavi G
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 182-184
|
| 3 |
Evaluation of in-vivo analgesic activity in mice using methanolic extract of Tribulus terrestris leaf
G Sudhakara Rao, Mujtaba Ahmed, T Shyam, Sameena Begum, Azaah Gafoor, Mohammed Abdul Razzaq, Ayesha siddiqua, D Chandrasekhar reddy, Anupama Priyadarshini, Onteru Snehitha and Sanikommu Varalakshmi
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 185-193
|
| 4 |
Avicennia officinalis: A mangrove marvel with multidimensional medicinal potential
Afra Fatima and M Sandhya Rani
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 194-200
|
| 5 |
Evaluation of antidiabetic and antioxidant potential of Mallotus apelta leaf extracts in streptozotocin-induced diabetic rats
Shubham Kishor Badgujar and Sandeep Sahu
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 201-206
|
| 6 |
A comprehensive review of phase IV trials and post-marketing surveillance
Durga Devi Surya Kumar Verma
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 207-214
|
| 7 |
Current status of pharmacogenetic testing and their impact on atypical antipsychotic medication
Durga Devi Surya Kumar Verma
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 215-218
|
| 8 |
Recognizing and managing the chronic obstructive pulmonary disease (COPD)
SK Nishabunnisha, Gnaneswari Ramakuri, Sudeepthi Tripurari, SK Shakeera Begum and Likhitha Mudhigonda
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 219-222
|
| 9 |
Case report. LDL increased after withdrawal of lovastatin therapy: Does it make sense to resume treatment given that, according to the latest important retrospective cohort study, LDL is not a true risk factor for cardiovascular disease?
Cesare Achilli
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 223-226
|
| 10 |
Management of helicobacter pylori infection-petic ulcer disease
Shaik Nashibunnisha, Naga Likhitha Mudigonda, Sudeepthi Tripurari, Shaik shakeera begum and Gnaneswari Ramakuri
Int. J. Pharmacol. Clin. Res., 2025; 7(2): 227-231
|
